Special Issues
Oral publishes Special Issues to create collections of papers on specific topics, with the aim of building a community of authors and readers to discuss the latest research and develop new ideas and research directions. Special Issues are led by Guest Editors, who are experts on the topic and all Special Issue submissions follow MDPI's standard editorial process.
The journal’s Editor-in-Chief and/or designated Editorial Board Member will oversee Guest Editor appointments and Special Issue proposals, checking their content for relevance and ensuring the suitability of the material for the journal. The papers published in a Special Issue will be collected and displayed on a dedicated page of the journal’s website. Further information on MDPI's Special Issue polices and Guest Editor responsibilities can be found here. For any inquiries related to a Special Issue, please contact the Editorial Office.
Assessment: Strategies for Oral Health Education
Deadline: 20 November 2026
Advances in Digital Orthodontics
Deadline: 20 November 2026
Recent Developments in Oral Health Research with Implications for Clinical Practice
Deadline: 20 December 2026
New Advances in Dental Education
Deadline: 20 December 2026
Oral Function, Nutrition, and Systemic Interactions in Dysphagia: Assessment, Mechanisms, and Rehabilitation Strategies
Deadline: 20 January 2027
Advances in Pediatric Dentistry: Prevention, Minimally Invasive Approaches and Clinical Innovations
Deadline: 20 February 2027
Oral Health in Athletes: Risks, Prevention, Management, and Education
Deadline: 20 March 2027
Diagnosis and Management of Special Needs Patients: Dental and Orthodontic Perspectives in Pediatric and Adult Populations
Deadline: 20 April 2027
Editorial Board Members’ Collection Series: Oral Health Management for Special Care Patients, 2nd Edition
Deadline: 30 May 2027
Advanced Radiographic Techniques in Endodontics
Deadline: 20 June 2027
Diagnosis and Management of Dental Anomalies
Deadline: 20 June 2027
New Insights into Oral Cancer: From Early Detection to Advanced Therapeutics
Deadline: 20 July 2027

